{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:15Z","timestamp":1791223575739,"version":"4.1.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Psoriatic arthritis (PsA) represents the articular component of the systemic psoriatic disease and the extra-cutaneous disorder most frequently found in patients with psoriasis. Besides the articular involvement, PsA is associated with several metabolic abnormalities such as insulin resistance, hypertension, diabetes and hyperuricemia. Uric acid is the final product of purine metabolism and the etiological substrate of gout. Accumulating evidence highlights the emerging role of hyperuricemia as a major cardiovascular risk factor. Moreover, different studies evaluated the interplay between hyperuricemia and psoriatic disease, suggesting that individuals affected by psoriasis or PsA might present higher serum levels of uric acid and that hyperuricemia might affect severity of clinical manifestations and degree of inflammation in PsA patients. In this review, we focus on the bidirectional relationship between uric acid and PsA, analyzing how uric acid may be involved in the pathogenesis of psoriasis\/PsA and how clinical manifestations of PsA and inflammatory mediators are affected by uric acid concentrations. Finally, the effects of anti-rheumatic drugs on uric acid levels and the potential benefit of urate-lowering therapies on psoriasis and PsA were summarized.<\/jats:p>","DOI":"10.3389\/fmed.2021.737573","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:50:01Z","timestamp":1632271801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications"],"prefix":"10.3389","volume":"8","author":[{"given":"Cesare","family":"Tripolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Ciaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Meliconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11926-013-0316-4","article-title":"Psoriatic arthritis: phenotypic variance and nosology","volume":"15","author":"Eder","year":"2013","journal-title":"Curr Rheumatol Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3899\/jrheum.190114","article-title":"Cardiovascular diseases in psoriasis and psoriatic arthritis","volume":"95","author":"Eder","year":"2019","journal-title":"J Rheumatol Suppl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"Rahimi-Sakak","year":"2019","journal-title":"BMC Cardiovasc Disord."},{"key":"B5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jid.1961.20","article-title":"Hyperuricemia and psoriasis","volume":"36","author":"Baumann","year":"1961","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI104379","article-title":"Uric acid metabolism in psoriasis","volume":"40","author":"Eisen","year":"1961","journal-title":"J Clin Invest."},{"key":"B7","first-page":"267","article-title":"A genetic and statistical study of psoriasis","volume":"3","author":"Steinberg","year":"1951","journal-title":"Am J Hum Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/1346-8138.15803","article-title":"Epidemiological survey of the psoriasis patients in the Japanese Society for Psoriasis Research from 2013 to 2018","volume":"48","author":"Kamiya","year":"2021","journal-title":"J Dermatol."},{"key":"B9","first-page":"167","article-title":"Atherosclerosis, some serum inflammatory markers in psoriasis","volume":"149","author":"Alpsoy","year":"2014","journal-title":"G Ital Dermatol Venereol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12291-011-0132-4","article-title":"C-reactive protein and uric Acid levels in patients with psoriasis","volume":"26","author":"Isha","year":"2011","journal-title":"Indian J Clin Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2230.2010.03988.x","article-title":"Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis","volume":"36","author":"Kwon","year":"2011","journal-title":"Clin Exp Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaad.2013.09.005","article-title":"Hyperuricemia in patients with chronic plaque psoriasis","volume":"70","author":"Gisondi","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e3676","DOI":"10.1097\/MD.0000000000003676","article-title":"Association of serum uric acid levels in psoriasis: a systematic review and meta-analysis","volume":"95","author":"Li","year":"2016","journal-title":"Medicine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ced.12781","article-title":"Psoriasis and uric acid: a population-based cross-sectional study","volume":"41","author":"Lai","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0003319716657980","article-title":"Impact of elevated serum uric acid levels on systemic inflammation in patients with psoriasis","volume":"68","author":"Solak","year":"2017","journal-title":"Angiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1590\/abd1806-4841.20187547","article-title":"Serum uric acid levels and hyperuricemia in patients with psoriasis: a hospital-based cross-sectional study","volume":"93","author":"Gui","year":"2018","journal-title":"An Bras Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/jid.1958.119","article-title":"Serum uric acid levels in psoriasis","volume":"31","author":"Lea","year":"1958","journal-title":"J Invest Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2133.1960.tb13860.x","article-title":"Serum cholesterol, uric acid and proteins in psoriasis","volume":"72","author":"Tickner","year":"1960","journal-title":"Br J Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00000372-198100340-00014","article-title":"Uric acid in the etiology of psoriasis","volume":"3","author":"Goldman","year":"1981","journal-title":"Am J Dermatopathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jdv.15290","article-title":"Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study","volume":"33","author":"Hu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.18553\/jmcp.2018.17421","article-title":"Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. Administrative claims data","volume":"25","author":"Kaine","year":"2019","journal-title":"J Manag Care Spec Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/IBPC.S184685","article-title":"Hyperuricemia and hypertension: links and risks","volume":"12","author":"Stewart","year":"2019","journal-title":"Integr Blood Press Control."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget."},{"key":"B26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.11613\/BM.2012.007","article-title":"Uric acid as one of the important factors in multifactorial disorders\u2013facts and controversies","volume":"22","author":"Pasalic","year":"2012","journal-title":"Biochem Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3435174","DOI":"10.1155\/2019\/3435174","article-title":"Uric acid provides protective role in red blood cells by antioxidant defense: a hypothetical analysis","volume":"2019","author":"Song","year":"2019","journal-title":"Oxid Med Cell Longev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr Pharm Des."},{"key":"B31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11926-011-0162-1","article-title":"The role of uric acid as an endogenous danger signal in immunity and inflammation","volume":"13","author":"Ghaemi-Oskouie","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.4049\/jimmunol.1400110","article-title":"Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa","volume":"192","author":"Hara","year":"2014","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.0105-2896.2009.00851.x","article-title":"Monosodium urate crystals in inflammation and immunity","volume":"233","author":"Shi","year":"2010","journal-title":"Immunol Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11926-010-0092-3","article-title":"Update on biology: uric acid and the activation of immune and inflammatory cells","volume":"12","author":"Martinon","year":"2010","journal-title":"Curr Rheumatol Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/qjmed\/hcr159","article-title":"Is there anything good in uric acid?","volume":"104","author":"Alvarez-Lario","year":"2011","journal-title":"QJM"},{"key":"B38","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1038\/s41598-019-46935-w","article-title":"Crystallized but not soluble uric acid elicits pro-inflammatory response in short-term whole blood cultures from healthy men","volume":"9","author":"Brovold","year":"2019","journal-title":"Sci Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12916-020-01873-7","article-title":"Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews","volume":"19","author":"Mentis","year":"2021","journal-title":"BMC Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.03.026","article-title":"Urate and the risk of Parkinson's disease in men and women","volume":"52","author":"Cortese","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0317167100012981","article-title":"Serum urate and the risk of Parkinson's disease: results from a meta-analysis","volume":"40","author":"Shen","year":"2013","journal-title":"Can J Neurol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40520-020-01541-z","article-title":"Uric acid and late-onset Alzheimer's disease: results from the ReGAl 2.0 project","volume":"33","author":"Boccardi","year":"2021","journal-title":"Aging Clin Exp Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"625690","DOI":"10.3389\/fnagi.2021.625690","article-title":"Serum uric acid and the risk of dementia: a systematic review and meta-analysis","volume":"13","author":"Zhou","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1177\/0300060517752996","article-title":"High serum uric acid levels are a protective factor against unfavourable neurological functional outcome in patients with ischaemic stroke","volume":"46","author":"Wang","year":"2018","journal-title":"J Int Med Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/s11033-020-05324-7","article-title":"The protective effect of uric acid in reducing TLR4\/NF-\u03baB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro","volume":"47","author":"Cheng","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2013.00161","article-title":"The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness","volume":"4","author":"Aroor","year":"2013","journal-title":"Front Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2017.06.006","article-title":"Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice","volume":"74","author":"Aroor","year":"2017","journal-title":"Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12902-021-00698-6","article-title":"Uric acid-induced pancreatic \u03b2-cell dysfunction","volume":"21","author":"Ghasemi","year":"2021","journal-title":"BMC Endocr Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","article-title":"Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease","volume":"98","author":"Ponticelli","year":"2020","journal-title":"Kidney Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1346-8138.12961","article-title":"Psoriatic T cells reduce epidermal turnover time and affect cell proliferation contributed from differential gene expression","volume":"42","author":"Li","year":"2015","journal-title":"J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","article-title":"Systemic effects of IL-17 in inflammatory arthritis","volume":"15","author":"Beringer","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/hep.23093","article-title":"Abnormal hepatic energy homeostasis in type 2 diabetes","volume":"50","author":"Szendroedi","year":"2009","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"E1255","DOI":"10.1152\/ajpendo.00214.2013","article-title":"The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis","volume":"305","author":"Petrie","year":"2013","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e30456","DOI":"10.1371\/journal.pone.0030456","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7573\/dic.2020-2-1","article-title":"Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors","author":"Fieldhouse","year":"2020","journal-title":"Drugs Context."},{"key":"B58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15257770.2013.854902","article-title":"ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion","volume":"33","author":"Takada","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ibd.20030","article-title":"Efflux transporters in ulcerative colitis: decreased expression of BCRP. (ABCG2) and Pgp. (ABCB1)","volume":"13","author":"Englund","year":"2007","journal-title":"Inflamm Bowel Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis: Review and update","volume":"214","author":"Perez-Chada","year":"2020","journal-title":"Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/DMSO.S232377","article-title":"Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications","volume":"13","author":"Gong","year":"2020","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B62","first-page":"188","article-title":"Renal effects of insulin in man","volume":"10","author":"Qui\u00f1ones-Galvan","year":"1997","journal-title":"J Nephrol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0026-0495(98)90346-8","article-title":"Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity","volume":"47","author":"Matsuura","year":"1998","journal-title":"Metabolism"},{"key":"B64","doi-asserted-by":"publisher","first-page":"F826","DOI":"10.1152\/ajprenal.00012.2017","article-title":"Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2","volume":"313","author":"Toyoki","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10067-020-04981-0","article-title":"At the crossroads of gout and psoriatic arthritis: \u201cpsout\u201d","volume":"39","author":"Felten","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jbspin.2012.08.006","article-title":"Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases","volume":"80","author":"Oliviero","year":"2013","journal-title":"Joint Bone Spine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.phrs.2019.104351","article-title":"IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation","volume":"147","author":"Raucci","year":"2019","journal-title":"Pharmacol Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"105092","DOI":"10.1016\/j.jbspin.2020.105092","article-title":"The role of interleukin-1 family members in hyperuricemia and gout","volume":"88","author":"Kl\u00fcck","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jid.2016.01.026","article-title":"Monosodium urate crystals induce functional expression of P2Y14 receptor in human keratinocytes","volume":"136","author":"Uratsuji","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/1440-1681.12765","article-title":"The release of pro-inflammatory cytokines is mediated via mitogen-activated protein kinases rather than by the inflammasome signalling pathway in keratinocytes","volume":"44","author":"Ondet","year":"2017","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4049\/jimmunol.1003746","article-title":"P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals","volume":"188","author":"Uratsuji","year":"2012","journal-title":"J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1535370219830665","article-title":"Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation","volume":"244","author":"Zamudio-Cuevas","year":"2019","journal-title":"Exp Biol Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/cmi.2011.35","article-title":"Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis","volume":"8","author":"Chen","year":"2011","journal-title":"Cell Mol Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-4684-4553-4_55","article-title":"Serum uric acid levels in psoriasis","volume":"165","author":"Scott","year":"1984","journal-title":"Adv Exp Med Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1002\/ddr.21201","article-title":"Hyperuricemia in patients with chronic plaque psoriasis","volume":"75","author":"Gisondi","year":"2014","journal-title":"Drug Dev Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"541709","DOI":"10.1155\/2014\/541709","article-title":"Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis","volume":"2014","author":"Ataseven","year":"2014","journal-title":"Dis Markers."},{"key":"B77","doi-asserted-by":"publisher","first-page":"rkab009","DOI":"10.1093\/rap\/rkab009","article-title":"Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis-a post-hoc analysis of pooled data from three phase 3 trials with secukinumab","volume":"5","author":"Dehlin","year":"2021","journal-title":"Rheumatol Adv Pract."},{"key":"B78","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","article-title":"Comorbidities in patients with gout prior to and following diagnosis: case-control study","volume":"75","author":"Kuo","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/ard.36.3.264","article-title":"Serum uric acid levels in psoriatic arthritis","volume":"36","author":"Lambert","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00124743-200002000-00001","article-title":"Hyperuricemia in psoriatic arthritis: prevalence and associated features","volume":"6","author":"Bruce","year":"2000","journal-title":"J Clin Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","article-title":"Psoriasis, psoriatic arthritis and risk of gout in US men and women","volume":"74","author":"Merola","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/1756-185X.13265","article-title":"Hyperuricemia in Asian psoriatic arthritis patients","volume":"21","author":"Lai","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3899\/jrheum.170384","article-title":"Characteristic and outcome of psoriatic arthritis patients with hyperuricemia","volume":"45","author":"AlJohani","year":"2018","journal-title":"J Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1346-8138.13968","article-title":"Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients","volume":"44","author":"Tsuruta","year":"2017","journal-title":"J Dermatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semarthrit.2008.06.001","article-title":"Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease","volume":"39","author":"Gonzalez-Gay","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"B86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejr.2012.03.002","article-title":"Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis","volume":"34","author":"Ibrahim","year":"2012","journal-title":"Egyptian Rheumatologist"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2040622320944777","DOI":"10.1177\/2040622320944777","article-title":"Changes in metabolic parameters in psoriatic patients treated with secukinumab","volume":"11","author":"Wang","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/jdv.16004","article-title":"Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients","volume":"34","author":"Gerdes","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5152\/eurjrheum.2020.20109","article-title":"The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis","volume":"7","author":"Karata\u015f","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00296-019-04394-6","article-title":"Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors","volume":"39","author":"Hasikova","year":"2019","journal-title":"Rheumatol Int."},{"key":"B91","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000252467","article-title":"Allopurinol in psoriasis","volume":"141","author":"Viglioglia","year":"1970","journal-title":"Dermatologica"},{"key":"B92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2133.1973.tb01921.x","article-title":"Allopurinol in psoriasis\u2013a double-blind study","volume":"89","author":"Feuerman","year":"1973","journal-title":"Br J Dermatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"490","DOI":"10.25122\/jml-2020-0065","article-title":"Impact of the synbiotics and urate-lowering therapy on gut microbiota and cytokine profile in patients with chronic gouty arthritis","volume":"13","author":"Kondratiuk","year":"2020","journal-title":"J Med Life."},{"key":"B94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40360-020-0386-7","article-title":"Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study","volume":"21","author":"Alghamdi","year":"2020","journal-title":"BMC Pharmacol Toxicol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/keaa425","article-title":"Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia","volume":"60","author":"Luis-Rodr\u00edguez","year":"2021","journal-title":"Rheumatology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"300060520902950","DOI":"10.1177\/0300060520902950","article-title":"The efficacy and tolerability of febuxostat treatment in a cohort of Chinese Han population with history of gout","volume":"48","author":"Huang","year":"2020","journal-title":"J Int Med Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3892\/etm.2018.6972","article-title":"Effects of febuxostat on serum cytokines IL-1, IL-4, IL-6, IL-8, TNF-\u03b1 and COX-2","volume":"17","author":"Hao","year":"2019","journal-title":"Exp Ther Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"105884","DOI":"10.1016\/j.intimp.2019.105884","article-title":"Febuxostat attenuates ulcerative colitis by the inhibition of NF-\u03baB, proinflammatory cytokines, and oxidative stress in mice","volume":"76","author":"Amirshahrokhi","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"105116","DOI":"10.1016\/j.ejps.2019.105116","article-title":"Role of allopurinol and febuxostat in the amelioration of dextran-induced colitis in rats","volume":"141","author":"El-Mahdy","year":"2020","journal-title":"Eur J Pharm Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1468-3083.2004.01184.x","article-title":"Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition","volume":"19","author":"Namazi","year":"2005","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.737573\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:50:09Z","timestamp":1632271809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.737573\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":100,"alternative-id":["10.3389\/fmed.2021.737573"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.737573","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"article-number":"737573"}}